| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jul 2, 2024 | Jul 3, 2024 | Stoke Therapeutics, Inc. | Chief Business Officer | Sell | 13.8 | -2,500 | -100.00% | ✓ | $32.8K |
| May 20, 2024 | May 22, 2024 | Stoke Therapeutics, Inc. | COO | Sell | 7.5 | -50,000 | -100.00% | ✓ | $769.5K |
| Apr 1, 2024 | Apr 3, 2024 | Stoke Therapeutics, Inc. | COO | Sell | 7.5 | -61,329 | -100.00% | ✓ | $811.2K |
| Mar 15, 2024 | Mar 19, 2024 | Stoke Therapeutics, Inc. | COO | Sell | 46.3 | -4,116 | -26.65% | ✗ | $25.1K |
| Jan 3, 2022 | Jan 5, 2022 | Stoke Therapeutics, Inc. | COO | Sell | 10.0 | -3,800 | -100.00% | ✓ | $87.7K |
| Dec 1, 2021 | Dec 3, 2021 | Stoke Therapeutics, Inc. | COO | Sell | 10.0 | -5,700 | -100.00% | ✓ | $139.3K |
| Nov 1, 2021 | Nov 3, 2021 | Stoke Therapeutics, Inc. | COO | Sell | 10.0 | -5,700 | -77.98% | ✓ | $137K |
| Oct 1, 2021 | Oct 4, 2021 | Stoke Therapeutics, Inc. | COO | Sell | 10.0 | -5,700 | -100.00% | ✓ | $141.5K |
| Sep 1, 2021 | Sep 2, 2021 | Stoke Therapeutics, Inc. | COO | Sell | 10.0 | -5,700 | -100.00% | ✓ | $148.2K |
| Aug 2, 2021 | Aug 4, 2021 | Stoke Therapeutics, Inc. | COO | Sell | 10.0 | -5,700 | -100.00% | ✓ | $164.6K |
| Jul 1, 2021 | Jul 2, 2021 | Stoke Therapeutics, Inc. | COO | Sell | 10.0 | -5,700 | -100.00% | ✓ | $190K |
| Jun 1, 2021 | Jun 3, 2021 | Stoke Therapeutics, Inc. | COO | Sell | 13.8 | -575 | -100.00% | ✓ | $22.7K |
| Jan 4, 2021 | Jan 6, 2021 | Stoke Therapeutics, Inc. | COO | Sell | 7.5 | -5,732 | -100.00% | ✓ | $338K |
| Dec 17, 2020 | Dec 18, 2020 | Stoke Therapeutics, Inc. | COO | Sell | 5.0 | -50,000 | -100.00% | ✓ | $3M |
| Dec 1, 2020 | Dec 3, 2020 | Stoke Therapeutics, Inc. | COO | Sell | 7.5 | -5,700 | -100.00% | ✓ | $284.1K |
| Nov 10, 2020 | Nov 10, 2020 | Stoke Therapeutics, Inc. | COO | Sell | 5.0 | -50,000 | -100.00% | ✓ | $2.3M |
| Nov 2, 2020 | Nov 4, 2020 | Stoke Therapeutics, Inc. | COO | Sell | 10.0 | -5,700 | -100.00% | ✓ | $212.1K |
| Oct 1, 2020 | Oct 5, 2020 | Stoke Therapeutics, Inc. | COO | Sell | 10.0 | -5,700 | -100.00% | ✓ | $196.9K |
| Sep 8, 2020 | Sep 10, 2020 | Stoke Therapeutics, Inc. | COO | Sell | 5.0 | -47,919 | -100.00% | ✓ | $1.4M |
| Sep 1, 2020 | Sep 3, 2020 | Stoke Therapeutics, Inc. | COO | Sell | 10.0 | -5,700 | -100.00% | ✓ | $158.1K |
| Aug 28, 2020 | Aug 31, 2020 | Stoke Therapeutics, Inc. | COO | Sell | 10.0 | -2,081 | -100.00% | ✓ | $62.4K |
| Aug 3, 2020 | Aug 4, 2020 | Stoke Therapeutics, Inc. | COO | Sell | 10.0 | -5,700 | -100.00% | ✓ | $140.9K |
| Jul 16, 2020 | Jul 17, 2020 | Stoke Therapeutics, Inc. | COO | Sell | 13.8 | -1,900 | -100.00% | ✓ | $47.6K |
| Jul 7, 2020 | Jul 9, 2020 | Stoke Therapeutics, Inc. | COO | Sell | 13.8 | -913 | -100.00% | ✓ | $20.5K |
| Jul 1, 2020 | Jul 2, 2020 | Stoke Therapeutics, Inc. | COO | Sell | 10.0 | -3,800 | -100.00% | ✓ | $88K |
| Jun 1, 2020 | Jun 3, 2020 | Stoke Therapeutics, Inc. | COO | Sell | 10.0 | -2,107 | -100.00% | ✓ | $57.3K |
| Mar 2, 2020 | Mar 4, 2020 | Stoke Therapeutics, Inc. | COO | Sell | 5.0 | -49,143 | -100.00% | ✓ | $1.3M |